Subtype
Kidney Neoplasm
CI-CAN-00002988Explore in graph →
Non-malignant481 active trials17 approved drugs80 evidence items
Loading cancer entity…
Subtype
CI-CAN-00002988Explore in graph →
Clinical trials
2,321 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00684996 | Bevacizumab With or Without MEDI-522 in Treating Patients With Unresectable or Metastatic Kidney Cancer | terminated | Phase 1 / Phase 2 | 5 | National Cancer Institute (NCI)NIH | 1 | May 15, 2014 | clinicaltrials |
| NCT02136121 | Prospective Investigation of Robotic Single-port System | completed | Phase 1 / Phase 2 | 19 | Intuitive SurgicalINDUSTRY | 1 | May 12, 2014 | clinicaltrials |
| NCT00353301 |
| Erlotinib and Sirolimus for the Treatment of Metastatic Renal Cell Carcinoma |
| completed |
| Phase 2 |
| 25 |
| University of Colorado, DenverOTHER |
| 1 |
| Apr 14, 2014 |
| clinicaltrials |
| NCT00193154 | OSI-774 and Bevacizumab in the Treatment of Patients With Metastatic Renal Cell Carcinoma | completed | Phase 2 | 63 | SCRI Development Innovations, LLCOTHER | 1 | Apr 1, 2014 | clinicaltrials |
| NCT01577784 | Pazopanib in Second-line Therapy in Renal Cell Carcinoma | unknown | Phase 2 | 27 | Associació per a la Recerca Oncologica, SpainOTHER | 1 | Mar 12, 2014 | clinicaltrials |
| NCT00004135 | Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney Cancer | completed | Phase 2 | 19 | University of ChicagoOTHER | 1 | Mar 7, 2014 | clinicaltrials |
| NCT00459979 | Sunitinib in Treating Patients With Kidney Cancer That Cannot Be Removed by Surgery | completed | Phase 2 | 30 | Case Comprehensive Cancer CenterOTHER | 1 | Mar 7, 2014 | clinicaltrials |
| NCT00891475 | Palliative Radiofrequency Ablation in Metastatic Renal Cell Carcinoma Patients | completed | Phase 1 / Phase 2 | 114 | Kidney Cancer Research BureauOTHER | 1 | Feb 13, 2014 | clinicaltrials |
| NCT00523640 | A Phase II Trial of Gemcitabine, Capecitabine, and Bevacizumab in Metastatic Renal Cell Carcinoma | terminated | Phase 2 | 30 | University of ChicagoOTHER | 1 | Feb 11, 2014 | clinicaltrials |
| NCT00045487 | Erlotinib in Treating Patients With Advanced Kidney Cancer(OSI-774) | completed | Phase 2 | 41 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Jan 27, 2014 | clinicaltrials |
| NCT00301990 | Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer | unknown | Phase 2 | 65 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00717587 | Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer | unknown | Phase 2 | 20 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00030888 | UCN-01 in Treating Patients With Advanced or Metastatic Kidney Cancer | unknown | Phase 2 | — | University of California, San FranciscoOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00176501 | Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer | terminated | Phase 2 | 3 | Rutgers, The State University of New JerseyOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00002846 | Interleukin-2 in Treating Patients With Metastatic or Recurrent Kidney Cancer | unknown | Phase 2 | 14 | Blumenthal Cancer Center at Carolinas Medical CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00002847 | Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer | unknown | Phase 2 | 14 | Blumenthal Cancer Center at Carolinas Medical CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00080977 | High-Dose Intravenous Interleukin-2 in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer) That Has Not Responded to Previous Low-Dose Intravenous or Subcutaneous Interleukin-2 | unknown | Phase 2 | — | Blumenthal Cancer Center at Carolinas Medical CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00093522 | Vaccine Therapy With or Without Fludarabine in Treating Patients With Stage IV Kidney Cancer | unknown | Phase 2 | 28 | St. Luke's Medical CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00002589 | Lymphocyte Therapy in Treating Patients With Kidney Cancer | unknown | Phase 2 | 90 | National Cancer Institute (NCI)NIH | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00586495 | Long-term Extension From RCC Phase II (11515) | completed | Phase 2 | 95 | BayerINDUSTRY | 1 | Dec 13, 2013 | clinicaltrials |
| NCT00003585 | Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer | completed | Phase 1 / Phase 2 | 35 | University of New MexicoOTHER | 1 | Dec 10, 2013 | clinicaltrials |
| NCT00003181 | Interleukin-2, Vinblastine, and GM-CSF in Treating Patients With Metastatic Kidney Cancer | unknown | Phase 2 | 35 | Hope Cancer Institute, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00003604 | Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer That Has Been Removed With Surgery | unknown | Phase 2 | 20 | Cancer Biotherapy Research GroupOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00003664 | Combination Chemotherapy and Biological Therapy In Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed Surgically | unknown | Phase 2 | 30 | Cancer Biotherapy Research GroupOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00293501 | Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By Surgery | unknown | Phase 1 / Phase 2 | 35 | University of VermontOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00110344 | Research Study for Patients With Metastatic Renal Cell Carcinoma | terminated | Phase 2 | 1 | BayerINDUSTRY | 1 | Oct 11, 2013 | clinicaltrials |
| NCT00005038 | Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Metastatic Kidney Cancer | unknown | Phase 2 | — | The Christie NHS Foundation TrustOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00036712 | Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation | unknown | Phase 2 | 80 | Medical College of WisconsinOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00025376 | PS-341 in Treating Patients With Metastatic Kidney Cancer | completed | Phase 2 | 23 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT00203866 | Trial of G250 Peptide and IL-2 Following Surgical Resection of Locally Advanced/Metastatic Renal Cell Carcinoma | terminated | Phase 2 | 40 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT00059813 | Oblimersen and Interferon Alfa in Treating Patients With Metastatic Renal Cell Cancer | completed | Phase 2 | 41 | National Cancer Institute (NCI)NIH | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00100906 | Sequential ATRA Then IL-2 for Modulation of Dendritic Cells and Treatment of Metastatic Renal Cell Cancer | completed | Phase 2 | 18 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Aug 16, 2013 | clinicaltrials |
| NCT00626509 | Sunitinib Before or After Surgery in Treating Patients With Metastatic Kidney Cancer | unknown | Phase 2 | 110 | Gruppo Italiano Carcinoma RenaleOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00873236 | MRI Scans of Blood Vessel Changes Caused by Bevacizumab Alone or Given Together With Interferon Alpha-2a in Treating Patients With Stage III or Stage IV Kidney Cancer | unknown | Phase 2 | 30 | Mount Vernon Cancer Centre at Mount Vernon HospitalOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT01024205 | Sunitinib Malate Before and After Surgery in Treating Patients With Previously Untreated Metastatic Kidney Cancer | completed | Phase 2 | 43 | Barts and the London School of Medicine and DentistryOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00027664 | Interferon Alfa With or Without Thalidomide in Treating Patients With Metastatic Kidney Cancer | unknown | Phase 2 | 90 | Cancer Research UKOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00025103 | Chemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplant in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the Kidney | unknown | Phase 2 | 75 | Children's Cancer and Leukaemia GroupOTHER | 2 | Aug 2, 2013 | clinicaltrials |
| NCT00323739 | Bevacizumab (Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal Carcinoma | completed | Phase 2 | 80 | SCRI Development Innovations, LLCOTHER | 1 | Jul 26, 2013 | clinicaltrials |
| NCT00557830 | Randomized Study of Sorafenib Dose Escalation in Patients With Previously Untreated Metastatic Renal Cell Carcinoma | terminated | Phase 2 | 12 | Accelerated Community Oncology Research NetworkOTHER | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00678119 | Study Testing the Biologic Activity and Safety of a Immunotherapeutic in Patients With Newly Diagnosed Advanced Stage Kidney Cancer in Combination With a Marketed Renal Cell Carcinoma Treatment | completed | Phase 2 | 25 | Argos TherapeuticsINDUSTRY | 2 | Jul 15, 2013 | clinicaltrials |
| NCT00025519 | Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer | withdrawn | Phase 2 | 0 | Fox Chase Cancer CenterOTHER | 0 | Jul 11, 2013 | clinicaltrials |
| NCT00002475 | Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer | completed | Phase 2 | 40 | St. Vincent Medical Center - Los AngelesOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00040989 | BAY 56-3722 in Treating Patients With Recurrent, Unresectable, or Metastatic Kidney Cancer | withdrawn | Phase 2 | 0 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00588913 | Adoptive Immunotherapy, Aldesleukin, and Zoledronate in Treating Patients With Stage IV Kidney Cancer and Lung Metastases | completed | Phase 1 / Phase 2 | 20 | Tokyo Women's Medical UniversityOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00003103 | Chemotherapy in Treating Patients With Solid Tumors | completed | Phase 1 / Phase 2 | 57 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00098618 | Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer | terminated | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00005056 | Bryostatin 1 In Treating Patients With Progressive Kidney Cancer | completed | Phase 2 | — | Cancer Research UKOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00030342 | Biological Therapy and Chemotherapy in Treating Patients With Metastatic Kidney Cancer or Colorectal Cancer | completed | Phase 1 / Phase 2 | 60 | St. Luke's Medical CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00003542 | Interferon Alfa in Treating Patients With Advanced Kidney Cancer | completed | Phase 1 / Phase 2 | 58 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 25, 2013 | clinicaltrials |
| NCT00002515 | Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
Data updated 23 days agoSource updated May 15, 2014source: clinicaltrials